HART News and Press, IQ Healthy Hearts ETF From 03/11/23

2023-03-11 04:42:25 ET Summary Fed's aggressive rate hikes, plus SVB crisis, are a big worry right now. Behind the scenes, a (related) biotech stock crisis is also brewing. Market internals remain weak and demand caution going forward. What do a major U.S. commercial...

2023-03-09 02:50:00 ET Summary Rates of change matter, especially for tech companies, and we would expect investors to react favorably to accelerating growth. In healthcare, we continue to find investment opportunities in a difficult macro environment. If the U.S. enters a tra...

2023-03-09 02:20:00 ET Summary Increasing selling pressure among biotech stocks is a major concern. While the market's intermediate-term path is still up, the short-term outlook is weakening. Beware higher volatility in March as healthcare sector selling pressure persists. ...

Summary We think healthcare companies are quite resilient during periods of inflation because their products are not substitutable and they deliver innovation. Healthcare has lagged behind many other areas in terms of its adoption of technology. We think, regardless of the market en...

Summary We think value stocks can outperform as interest rates head higher. Regions and sectors help us find quality within value and growth at a reasonable price. Stocks slid after the Federal Reserve’s preferred inflation gauge showed persistently high inflation, reinforcing wh...

Summary When I think about the lessons learned from 2022, I think the biggest lesson is valuations matter. I do think this is the most predicted recession that I've ever seen, certainly, in my career. Investors of all stripes, whether you're an asset allocator or a stock picker, I t...

Summary Even in its battered condition, the therapeutics sub-sector still accounts for 9.1% of the Russell 2000 Growth index. M&A activity continues to heat up as big players—currently flush with cash—look to drive growth by filling their development pipelines. In ...

Summary Healthcare stocks have remained in vogue through volatile markets, driven by increased interest in the sector during COVID-19. During a painful year for equity investors in 2022, healthcare stocks offered a pocket of relative stability. Global healthcare stocks ended the yea...

Summary How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector. How staff shortages in the health care sector may also impact investors. Health care managed to outperform the S&P 500 last yea...

Summary The top two mega themes in terms of global net inflows in 2022 were Climate Change-related themes and Big Data. The largest net outflows came from tech-heavy themes, led by Robotics & Automation. 2023 may bring a return to more normal markets driven by economics rather t...